Literature DB >> 6786322

Calculating the dose of factor VIII in the management of haemophilia.

G I Ingram.   

Abstract

Three methods of calculating the dose of factor VIII have been compared. A simple formula based on body weight has been found satisfactory for cryoprecipitate and freeze-dried concentrate; but where body fluid build departs markedly from average, height should probably also be taken into account. Modifications for children are noted.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6786322

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  7 in total

1.  Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients.

Authors:  Séverine Henrard; Niko Speybroeck; Cedric Hermans
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

2.  Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs.

Authors:  A Messori; G Longo; M Morfini; S Cinotti; E Filimberti; G Giustarini; P Rossi Ferrini
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Evidence-Based Minireview: For overweight or obese persons with hemophilia A, should factor VIII dosing be based on ideal or actual body weight?

Authors:  Nicoletta Machin; Ming Y Lim
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.

Authors:  A Messori; G Longo; M Matucci; M Morfini; P L Ferrini
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

5.  Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis.

Authors:  Alanna McEneny-King; Pierre Chelle; Severine Henrard; Cedric Hermans; Alfonso Iorio; Andrea N Edginton
Journal:  Pharmaceutics       Date:  2017-10-17       Impact factor: 6.321

Review 6.  The History of Clotting Factor Concentrates Pharmacokinetics.

Authors:  Massimo Morfini
Journal:  J Clin Med       Date:  2017-03-20       Impact factor: 4.241

7.  Management of ruptured sinus of valsalva for device closure in a patient with haemophilia.

Authors:  Ira Dhawan; Arindam Choudhury; Shivani Aggarwal; Sandeep Chauhan
Journal:  Ann Card Anaesth       Date:  2020 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.